All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Biomarker Of Cancers

Biomarkers of Cancer have many potential applications in oncology; including risk assessment, disease screening, and different diagnoses, diagnoses determination, prognosis, and disease outbreaks. Because of the critical role played by biomarkers in the least stages of the disease, it's important that they undergo rigorous screening, including diagnostic validation, clinical validation, and clinical use tests, before being included in standard clinical care. In this review we talk about the important steps in the formation of biomarkers, including how to avoid bias presentation and guidelines to follow when reporting biomarker studies. Cancer biomarkers (CB) are biomolecules produced by the intestinal cells or other body cells in response to tumour. Every cell type has its own unique molecular signature and signals that identify as the levels or functions of many tens of genes, proteins, or other cellular features; therefore, biomarkers can facilitate the understanding of cancer cells. Our goal is to provide updated information and to do detailed research on CB regarding their molecular properties and their clinical utility in the diagnosis, diagnosis, follow-up, or treatment of cancerous diseases. Focusing on the mainstream, the FDA has authorized and promised future marketers in the most common sectors. In addition, an emphasis on their potential role can be very helpful in improving the management of patients with cancer.

High Impact List of Articles

Relevant Topics in Biochemistry